Evidence map›Paper›PMID 23146171›Full record

ArticleBMC bioinformatics2012

Effects of protein interaction data integration, representation and reliability on the use of network properties for drug target prediction.

Antonio Mora, Ian M Donaldson

Abstract read
In one paragraph

Article in BMC bioinformatics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Topological network measures for drug repositioning.Briefings in bioinformatics · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Protein-protein interaction detection: methods and analysis.International journal of proteomics · 2014
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Antonio MoraDepartment for Molecular Biosciences, University of Oslo, Norway.
Ian M Donaldson

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious studies have noted that drug targets appear to be associated with higher-degree or higher-centrality proteins in interaction networks. These studies explicitly or tacitly make choices of different source databases, data integration strategies, representation of proteins and complexes, and data reliability assumptions. Here we examined how the use of different data integration and representation techniques, or different notions of reliability, may affect the efficacy of degree and centrality as features in drug target prediction.

resultsFifty percent of drug targets have a degree of less than nine, and ninety-five percent have a degree of less than ninety. We found that drug targets are over-represented in higher degree bins - this relationship is only seen for the consolidated interactome and it is not dependent on n-ary interaction data or its representation. Degree acts as a weak predictive feature for drug-target status and using more reliable subsets of the data does not increase this performance. However, performance does increase if only cancer-related drug targets are considered. We also note that a protein's membership in pathway records can act as a predictive feature that is better than degree and that high-centrality may be an indicator of a drug that is more likely to be withdrawn.

conclusionsThese results show that protein interaction data integration and cleaning is an important consideration when incorporating network properties as predictive features for drug-target status. The provided scripts and data sets offer a starting point for further studies and cross-comparison of methods.

Indexed as

Drug Delivery SystemsHumansProtein Interaction MapsProteinsProteins

Identifiers

PMID23146171
PMCPMC3534413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.